Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 18, 2007Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 16, 2007Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information